A patient presents to the emergency department with severe anticholinergic toxicity, including delirium, tachycardia, mydriasis, and urinary retention after ingesting an unknown substance. The physician considers administering an antidote. Which medication is a centrally-acting acetylcholinesterase inhibitor used to reverse these effects?

1. A

   Atropine

2. B

   Pralidoxime

3. C

   Physostigmine

4. D

   Naloxone

Appeared in: NORCET 9 Prelims-2025

Explanation

Listen in Hindi

• Physostigmine is a reversible acetylcholinesterase inhibitor, which increases the amount of acetylcholine in the synapse to overcome the anticholinergic blockade.
• It is a tertiary amine, meaning it is lipid-soluble and can cross the blood-brain barrier.
• This central action is essential for reversing the neurological symptoms of severe anticholinergic toxicity, such as delirium and hallucinations.
• It also reverses peripheral symptoms like tachycardia and urinary retention.

Why Other Options Were Wrong

• Option A: Atropine is a competitive muscarinic antagonist; it is the prototype anticholinergic drug. Administering it would worsen the patient's anticholinergic toxicity.
• Option B: Pralidoxime is a cholinesterase reactivator, not an inhibitor. Its specific function is to break the bond between organophosphates and the acetylcholinesterase enzyme.
• Option D: Naloxone is a pure opioid antagonist. It works by competing with opioids for receptor sites in the brain.

Related Visual

• Visual 1: Diagram - A diagram of a cholinergic synapse illustrating how physostigmine inhibits the acetylcholinesterase enzyme, leading to an increase in acetylcholine concentration in the synaptic cleft.
• Visual 2: Infographic - An infographic illustrating the signs and symptoms of the anticholinergic toxidrome using the mnemonic 'Hot as a hare, Blind as a bat, Dry as a bone, Red as a beet, Mad as a hatter'.

Clinical Relevance

• Nursing practice connection: Prioritize focused assessment, early escalation, and real-time monitoring when managing Pharmacology: Antidotes for Drug Toxicity in acute care settings.
• Recognizing the anticholinergic toxidrome is a critical nursing skill in the emergency setting, as many over-the-counter and prescription drugs can cause it (e.g., antihistamines, tricyclic antidepressants, atropine).
• Administration of physostigmine carries significant risks, including inducing a cholinergic crisis (bradycardia, seizures, bronchospasm). Continuous cardiac monitoring and having atropine at the bedside are essential patient safety measures.
• What if? If the patient presented with pinpoint pupils, drooling, wheezing, and muscle twitching (a cholinergic crisis, e.g., from organophosphate poisoning), the correct treatment would be Atropine and Pralidoxime, not Physostigmine.

How to Approach the Question

• First, identify the clinical syndrome presented in the question stem. The combination of delirium, tachycardia, mydriasis, and urinary retention points directly to severe anticholinergic toxicity.
• Next, understand the question's specific requirement: an antidote that is a 'centrally-acting acetylcholinesterase inhibitor'. This means the drug must work in the brain and must block the enzyme that breaks down acetylcholine.
• Evaluate each option based on its known mechanism of action.
• Atropine is an anticholinergic, so it's the cause, not the cure. Eliminate it.
• Pralidoxime is for organophosphate poisoning. Eliminate it.
• Naloxone is for opioid overdose. Eliminate it.

Concept Tested & Keywords

• Concept Tested: Pharmacology: Antidotes for Drug Toxicity
• Stem keywords: anticholinergic toxicity, delirium, tachycardia, mydriasis, urinary retention, antidote, centrally-acting acetylcholinesterase inhibitor
• Lead-in keywords: Which medication
• Clinical cues: Patient presents with a classic anticholinergic toxidrome (delirium, tachycardia, mydriasis, urinary retention), indicating the need for a specific reversal agent.

Question ID

QCGcpD5wooHGBlkZVhzuWH

Copy ID